Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 2.02, 9.01 · 8-K

SANUWAVE Health, Inc.

SNWVNASDAQEQUITYCurrent

Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On August 6, 2026, Sanuwave Health, Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the second quarter ended June 30, 2026. As previously announced, a business update via conference call will occur on August 7, 2026 at 8:30 am EST.…

Filed Aug 6, 2026Accepted Aug 6, 2026, 5:07 PM EDTCIK 1417663Accession 0001628280-26-054459
Share

Company context

Current securities

Recent company filings

  1. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingSep 25, 2026
  2. SCHEDULE 13G/A filingAug 14, 2026
  3. 10-Q filingAug 6, 2026
  4. SCHEDULE 13G/A filingJul 31, 2026
  5. Results of Operations and Financial ConditionJul 13, 2026

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition. On August 6, 2026, Sanuwave Health, Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the second quarter ended June 30, 2026. As previously announced, a business update via conference call will occur on August 7, 2026 at 8:30 am EST. Materials are provided on the Company’s website at www.sanuwave.com/investors. The information in this Item 2.02 of this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.